Phase 2 Study - Erdosteine in Patients With CB/COPD
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This clinical study is designed to explore dose ranging and identify methods to demonstrate
the efficacy of Erdosteine in patients with stable Chronic Bronchitis associated with Chronic
Obstructive Pulmonary Disease.